Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pain, Motivation, Migraine, and the Microbiome: New Frontiers for Opioid Systems and Disease

Molecular Pharmacology(2020)10.1124/mol.120.119438Source: DataRank Database

Pain, Motivation, Migraine, and the Microbiome: New Frontiers for Opioid Systems and Disease is a research paper published in Molecular Pharmacology (2020). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.94)OA: bronzeTopics (48)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Elizabeth Sugiarto ORCID,Anna M.W. Taylor ORCID,Amynah Pradhan ORCID,Ream Al‐Hasani ORCID,Kyle E. Parker ORCID

Live enrichment

PubMed:32958571 OpenAlex:https://openalex.org/W3045892068

NIDA NIH HHS

Grant: R21 DA048650

NIDA NIH HHS

Grant: R00 DA038725

NIDA NIH HHS

Grant: K99 DA038725

NINDS NIH HHS

Grant: R21 NS109862

NIDA NIH HHS

Grant: R01 DA040688

FWCI

0.94

Citation Percentile

0.7%

Citation Trend

2020

2021

2022

2023

2025

bronzeLicense: https://www.elsevier.com/legal/tdmrep-license

journalhttps://molpharm.aspetjournals.org/content/molpharm/98/4/433.full.pdf

publisherhttps://molpharm.aspetjournals.org/content/molpharm/98/4/433.full.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0026895X24010460?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0026895X24010460?httpAccept=text/plain

publisherhttps://syndication.highwire.org/content/doi/10.1124/mol.120.119438

Fields of Study

Neuropeptides and Animal PhysiologyMigraine and Headache StudiesPain Mechanisms and TreatmentsAnalgesics, OpioidAnimalsGastrointestinal MicrobiomeHumansMigraine DisordersMotivationOpioid-Related DisordersPainReceptors, OpioidReceptors, Opioid, deltaReceptors, Opioid, kappaSignal TransductionNociceptin Receptor

MeSH Terms

Gastrointestinal MicrobiomeNociceptin ReceptorAnalgesics, OpioidAnimalsHumansMigraine DisordersMotivationOpioid-Related DisordersPainReceptors, OpioidSignal TransductionReceptors, Opioid, deltaReceptors, Opioid, kappa

Keywords

Nociceptin receptorDysphoriaOpioidChronic painMigraineDiseaseMedicineAddictionκ-opioid receptorNeuroscienceBioinformaticsδ-opioid receptorMicrobiomePsychiatryPsychologyOpioid peptideReceptorBiologyInternal medicine

Sustainable Development Goals

SDG 0: Good health and well-being